RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.
Event:
ESC Congress 2024
Topic:
Biotherapies
Session:
Biotherapies in cardiovascular disease: from bench to bedside
